CA2154896A1 - Agents immunoreactifs utilisant des heterodimeres - Google Patents
Agents immunoreactifs utilisant des heterodimeresInfo
- Publication number
- CA2154896A1 CA2154896A1 CA002154896A CA2154896A CA2154896A1 CA 2154896 A1 CA2154896 A1 CA 2154896A1 CA 002154896 A CA002154896 A CA 002154896A CA 2154896 A CA2154896 A CA 2154896A CA 2154896 A1 CA2154896 A1 CA 2154896A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- reagent
- residue
- mrp8
- subunit proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1054493A | 1993-01-28 | 1993-01-28 | |
US010544 | 1993-01-28 | ||
PCT/US1994/000965 WO1994016741A1 (fr) | 1993-01-28 | 1994-01-26 | Reactants immunoreactifs utilisant des heterodimeres |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2154896A1 true CA2154896A1 (fr) | 1994-08-04 |
Family
ID=21746245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002154896A Abandoned CA2154896A1 (fr) | 1993-01-28 | 1994-01-26 | Agents immunoreactifs utilisant des heterodimeres |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0681484A1 (fr) |
JP (1) | JPH08509955A (fr) |
AU (1) | AU6128694A (fr) |
CA (1) | CA2154896A1 (fr) |
WO (1) | WO1994016741A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000507233A (ja) * | 1996-03-13 | 2000-06-13 | デュポン ファーマシューティカルズ カンパニー | 新規の三元複合体放射性薬剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863713A (en) * | 1986-06-23 | 1989-09-05 | The Board Of Trustees Of Leland Stanford Jr. Univ. | Method and system for administering therapeutic and diagnostic agents |
US5124471A (en) * | 1990-03-26 | 1992-06-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Bifunctional dtpa-type ligand |
-
1994
- 1994-01-26 CA CA002154896A patent/CA2154896A1/fr not_active Abandoned
- 1994-01-26 WO PCT/US1994/000965 patent/WO1994016741A1/fr not_active Application Discontinuation
- 1994-01-26 EP EP94907897A patent/EP0681484A1/fr not_active Withdrawn
- 1994-01-26 AU AU61286/94A patent/AU6128694A/en not_active Abandoned
- 1994-01-26 JP JP6517316A patent/JPH08509955A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH08509955A (ja) | 1996-10-22 |
WO1994016741A1 (fr) | 1994-08-04 |
EP0681484A1 (fr) | 1995-11-15 |
AU6128694A (en) | 1994-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0173629B1 (fr) | Complexes d'ions métalliques conjugés avec des anticorps | |
US4741900A (en) | Antibody-metal ion complexes | |
US5171563A (en) | Cleavable linkers for the reduction of non-target organ retention of immunoconjugates | |
JPH0749377B2 (ja) | 機能的特異性抗体 | |
JPH06501703A (ja) | 治療用及び診断用撮像組成物及び方法において役立つ錯化剤及びターゲティング放射性免疫試薬 | |
JPH03500419A (ja) | 多特異抗白血球結合体及び哺乳動物用非経口的注射剤 | |
JPH10501220A (ja) | 放射性核種による放射性免疫検出および放射性免疫療法のためのタンパク質のチオール化 | |
CA2150477A1 (fr) | Ciblage sequentiel des sites tumoraux a l'aide de conjugues oligonucleotidiques d'anticorps et de conjugues oligonucleotidiques complementaires de radionucleides chelates | |
JPH06507918A (ja) | in vivo 結合対プレターゲティング | |
JP2975676B2 (ja) | 架橋抗体とその製法 | |
JP3074160B2 (ja) | 悪性腫瘍用画像化剤 | |
EP0675737A1 (fr) | Reactifs a reactivite immunologique utilisant la dihydrofolate reductase | |
CA2157902A1 (fr) | Ciblage de tumeurs a l'aide de conjugues d'oligonucleotide l-enantiomeres d'immunoreactifs et de radionucleides chelates | |
CA2113578A1 (fr) | Composes trifonctionnels specifiques de cellules multiresistantes | |
Mattes | Pharmacokinetics of Antibodies and their Radiolabels | |
WO1994029333A1 (fr) | Reactifs immunoreactifs utilisant la monoamine-oxydase | |
CA2154896A1 (fr) | Agents immunoreactifs utilisant des heterodimeres | |
Li et al. | Prelabeling of Chimeric Monoclonal Antibody L6 with 90Yttrium-and 111Indium-1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N‴-tetraacetic acid (DOTA) Chelates for Radioimmunodiagnosis and Therapy | |
EP4230637A1 (fr) | Complexes radioactifs d'anticorps anti-her2 et produit radiopharmaceutique | |
US7713528B1 (en) | Method for in vivo delivery of active compounds using reagent conjugate | |
Frey | Preparation, characterization and biological evaluation of cellobiose and dextran carriers of prosthetically labeled iodine-125 for use in radioimmunotherapy of tumors of glial origin | |
JPH06509102A (ja) | 体内造影抗イディオタイプ抗体を用いた組織特異的造影剤 | |
Pollack et al. | Hydrazino-type N 2 S 2 chelators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |